The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Livazo 1mg film-coated tablets



Kowa Pharmaceutical Europe GmbHPA2324/001/001

Main Information

Trade NameLivazo 1mg film-coated tablets
Active SubstancesPitavastatin calcium
Dosage FormFilm-coated tablet
Licence HolderKowa Pharmaceutical Europe GmbH
Licence NumberPA2324/001/001

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA08 pitavastatin

Status

License statusAuthorised
Licence Issued05/11/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back